Latest News
BD receives FDA clearance for Surgiphor 1000mL irrigation system
...
United Therapeutics' ralinepag reduces risk of clinical worsening in pivotal PAH study
2 March 2026 - Biotechnology company United Therapeutics Corporation (Nasdaq:UTHR) announced on Monday that its long-term pivotal phase 3 ADVANCE OUTCOMES study of ralinepag met the primary endpoint, showing a 55% reduction in the risk of clinical wo...
Genentech's fenebrutinib meets primary endpoint in pivotal Phase III study for multiple sclerosis
2 March 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Monday that its Phase III FENhance 1 study in relapsing multiple sclerosis (RMS) met the primary endpoint, showing that fenebrutin...
ValiRx establishes animal health subsidiary to target veterinary oncology market
2 March 2026 - Life science company ValiRx PLC (AIM: VAL) revealed on Monday that it has established a wholly owned subsidiary, ValiRx Animal Health Limited, to develop and commercialise its oncology assets within the veterinary market.The new entity...
FDA accepts rusfertide NDA and grants priority review for polycythemia vera
2 March 2026 - Japanese pharmaceutical company Takeda (TSE:4502) (NYSE:TAK) and US biopharmaceutical company Protagonist Therapeutics Inc (NASDAQ:PTGX) announced on Monday that the US Food and Drug Administration (FDA) has accepted the New Drug Appli...